Innovation and Market Leadership: Twist Biosciences NASDAQ:TWST , a leader in synthetic DNA products, is set for substantial growth with its new Express Genes service, offering NGS-verified genes in just five to seven business days. This innovation is expected to strengthen Twist's market position and dominance. Growth Forecast and Market Expansion: The company...
Malaysia Genomics Resource Centre ( MGRC ). There was a “triangle” in chart. So..so. It’s high “probability” that the “deep pullback” since Oct 21 is just a “correction “. Price will eventually “exceed” 2.72 (potential of more than 1000% growth!!) After price build its “base” @ 0.180 +/-.
I feel like in a few years from now this could go up from where we are now. Nobody believes in cathie wood anymore but genomics is the future. But this got way ahead of itself. I don't expect this to moon anytime soon also
NASDAQ:BNGO [/symbol With recent news, the future is looking good for BNGO. Biden signed ALS Law, this will result in $100m a year going into R&D for therapeutics and treatment; for ALS. Mayo clinic, a ALS Clinic, is already using BNGO. As well there is a projected 1500+ attendees at the moment for Symposiums2022. With pictures of the new system set to come out...
We are bounching from the 0.618 fib. Probably going to end up in the upper channel. Question if it can break to the upside?
Watching to see what happens with this chart pattern we're seeing form on ARKG. Over the last few months the ARK funds have been in the spotlight as funds that won't be able to perform well past the initial hype. Will ARKG be able to take back its glory or breakdown to lower levels? We'll see.
Love the stock and the company so got nothing else to do but wait this out. Holding about 20k shares. Short-term PT --- R1 $6.53 R2 $6.72 R3 $7.63-7.67 ... Near-term PT ~ $13.52 ... Long-term PT ~ $40-60 (let's settle on $50). Let me know what you guys think.
Prime setup for $ARKG as we hit the midway point of Bloody September, the worst month for returns. We've already seen several pullbacks, and with quad witching coming on Sept 17, we're bound to see some volatility. I fully expect ARKG to fall a little further as the broader market bleeds, but come the quad witching hour, you'll start to see the tides shifting....
Hello dear padawans. Short and sweet analysis on Invitae: $NVTA on long term support. It is also oversold. Given the lower shadow of current candle investors have strong appetite for current prices On the flip side one could venture reading the long term formation as a head and shoulders pattern. If you are a long term investor, buying here is a no brainer...
It looks like wave 2 has not completed yet. If we get a bounce and rejection off of the DTL and PoC line, and break the support around 82, we could see a completion of wave 2 around 75-76 followed by wave 3 to 110+
these four are signficant players in the genome sequencing market, but RHHB stock price hasn't take off in the same way, and Agilent is way out in front. Does this make RHHB a good buy, or, is there something wrong, and making the others a better prospect? Is Agilent a sell?
Bionano Genomics - BNGO - Trending higher? B-I-N-G-O! Above 61.8 fib and Moving Averages
This play looks tempting ngl. NASDAQ:BNGO Bionanon made very tasty returns so why not return. Price is near 0+/- ATR in keltner and if it closes above I will enter. Last time I entered around $5 and avg'ED up till $5.6. Took Profit around $14 but this chart looks promising. Genomics is still an underrated sector and there are many supporters of its hot...
ARKG looks like a double bounce at the bottom of thee channel, which is also the 0.382 retracement of the wave 4. Probably a little bit more channeling here before we get going. If we get a reversal here, wave 5 should bring us to anywhere between 145-160 by EoY
Here is my follow up update on original CRSP swing short trade idea I put up on January 14th. On this post, I am zooming out to weekly chart, looking at longer time frame to capture cyclical trends. Going back all the way to 2017 inception period, the higher than average volatilities are pretty easy to notice. It moves up really fast but also coming down. Every...
$BNGO Ready to breaks the resistance. If it breaks the triangle pattern, the nest level will be $15.
The short volume ratio is decreasing which means good news for us. - Fintel Also looks like it's time for a reversal on the 1HR MACD so we could be in for a breakout with a high upside. All I'm hearing is nothing but good news associated with Bionano Genomics. However, we cannot fail to ignore the declining revenues every year. Keep an eye on this till the next...